Tech Company Financing Transactions
Vaxxas Funding Round
Brandon Capital Partners, HealthCare Ventures and OneVentures invested in a $20 million Series B venture round for Vaxxas. The round was announced by the company on 2/10/2015.
Transaction Overview
Company Name
Announced On
2/10/2015
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Proceeds Purpose
The raise comes as Vaxxas is hitting the most critical point in its development. Later this year, it'll finally begin testing its technology in humans.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
47 Thorndike St. B1-1
Cambridge, MA 02141
USA
Cambridge, MA 02141
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Vaxxas is focussed on enhancing the performance of existing and next generation vaccines through the development and commercialization of the company's novel vaccine delivery technology - the Nanopatch.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Hoey
Chief Operating Officer
Angus Forster
VP - Engineering
Michael Junger
VP - Operations
Charles Ross
Browse more venture capital transactions:
Prev: 2/10/2015: Rainforest QA venture capital transaction
Next: 2/10/2015: TinderBox venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs